Upadacitinib Effective in PsA After TNF Inhibitor Failure



Upadacitinib is linked to effective clinical responses in patients with psoriatic arthritis who have received prior TNF inhibitor therapy.
Medscape Medical News



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *